Section Arrow
SCLX.NASDAQ
- Scilex Holding Company
Quotes are at least 15-min delayed:2026/04/25 05:36 EDT
Regular Hours
Last
 6.69
-0.25 (-3.60%)
Day High 
7.05 
Prev. Close
6.94 
1-M High
7.77 
Volume 
28.24K 
Bid
6.65
Ask
7
Day Low
6.64 
Open
7.05 
1-M Low
4.2 
Market Cap 
48.81M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 6.64 
20-SMA 6.76 
50-SMA 7.6 
52-W High 34.27 
52-W Low 3.92 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-36.48/0.73
Enterprise Value
84.44M
Balance Sheet
Book Value Per Share
-29.54
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
30.25M
Operating Revenue Per Share
6.61
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PFEPfizer27+0.33+1.24%19.61PE
OGNOrganon & Co11.26+2.66+30.93%11.87PE
NVONovo-Nordisk A/S41.17+2.65+6.88%10.72PE
ABBVABBVIE198.71-2.24-1.11%84.84PE
MRKMerck & Co111.9-2.72-2.37%15.67PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.